Mark Sheptoff Financial Planning’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-700
Closed -$7.86K 515
2025
Q4
$7.86K Buy
+700
New +$8.01K ﹤0.01% 374
2016
Q1
Sell
-25
Closed -$1K 352
2015
Q4
$1K Sell
25
-292
-92% -$9.08K ﹤0.01% 346
2015
Q3
$9K Hold
317
0.01% 256
2015
Q2
$13K Hold
317
0.01% 250
2015
Q1
$16K Sell
317
-62
-16% -$2.87K 0.01% 238
2014
Q4
$17K Buy
+379
New +$14.9K 0.02% 228

Other funds holding AVNS

Mark Sheptoff Financial Planning's AVNS Position: Q1 2026 in Review

Mark Sheptoff Financial Planning sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 700 shares — an estimated $7.86K sold.

Mark Sheptoff Financial Planning first reported a position in AVNS in Q4 2014 and held it in 6 quarters. The position peaked at $17K in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Mark Sheptoff Financial Planning reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 700 Avanos Medical shares in Q1 2026, an estimated $7.86K.
  • Mark Sheptoff Financial Planning first reported a position in Avanos Medical in Q4 2014 and held it in 6 quarters.
  • Mark Sheptoff Financial Planning's Avanos Medical position peaked at $17K in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.